导语
《中国医学院士文库》从文化出版与医疗卫生这两个行业的结合点上,准确地把握住了军地医务人员对弘扬医德医风、提升医疗技术的深层需求和期待,广大医务人员可以从中领略、学习到我国医学界名医大家不畏艰辛的奋斗历程、科学严谨的治学风范、勇于创新的学术精神、开阔深刻的思维品质。
《周宏灏院士集(精)》作为丛书之一,充分诠释了周宏灏院士的学术成就、学术思想和学术风范,可供广大医学工作者学习、借鉴。
内容提要
《周宏灏院士集》是《中国医学院士文库》的分册之一。本书由六部分组成。第一部分奋斗历程,介绍了院士的主要经历和事业发展的宝贵经验;第二部分学术贡献,包括院士的主要学术论文、学术著作以及学术年表等,反映了院士在理论创新和技术进步方面的主要成果及其价值;第三部分治学之道,阐述了院士的创新意识、严谨作风和刻苦精神;第四部分大师风范,记载了院士在培养人才和团队建设上为人师表的生动事例;第五部分社会影响,汇集了社会各界对院士学术成果和先进事迹的评价和赞誉;第六部分人生风采,以丰富的图片资料展示了院士在不同时期工作、讲学、国际交流、社会活动和业余生活等方方面面的风采。全书充分诠释了周宏灏院士的学术成就、学术思想和学术风范,可供广大医学工作者,特别是从事遗传药理学临床、科研、教学的专业人员学习、借鉴。
目录
第一部分 奋斗历程
中国遗传药理学的开拓者——记中国工程院院士周宏灏
第二部分 学术贡献
一、周宏灏院士的学术成就与学术思想
二、周宏灏院士的主要学术论文
Single-Dose Pharmacokinetics of Ceftriaxone in Healthy Chinese Adults
Racial Differences in Drug Response——Altered Sensitivity to and Clearance of Propranolol
in Men of Chinese Descent as Compared with American Whites
Interindividual Differences in β-receptor Density Contribute to Variability in Response
to β-adrenoceptor Antagonists
Induction of Polymorphic 4'-hydroxylation of S-mephenytoin by Rifampicin
Quinidine Reduces Clearance of(+)-Propranolol More than(一)-Propranolol Through
Marked Reduction in 4-Hydroxylation
Differences in Plasma Binding of Drugs Between Caucasians and Chinese Subjects
Increased Suppression of Exercise-Induced Increase in Renin by Propranolol in Chinese
Subjects
Lack of Effect of Ageing on the Stereochemical Disposition of Propranolol
Differing Effect of Atropine on Heart Rate in Chinese and White Subjects
Ethnic Differences in Response tO Morphine
Stereoselective Disposition of Carvedilol is Determined by CYP2D6-
The Elimination of Diazepam in Chinese Subjects is Dependent on the Mephenytoin
Oxidation Phenotype
In Vivo Inhibition of CYP2C19 But Not CYP2D6 by Fluvoxamine
Genetic Polymorphisms of Debrisoquine and S-mephenytoin Oxidation Metabolism
in Chinese Populations:a Meta-analysis
Differences in the Incidence of the CYP2C19 Polymorphism Affecting the S-Mephenytoin
Phenotype in Chinese Han and Bai Populations and Identification of a New Rare CYP2C19
Mutant Allele
Evidence for the Effect of Gender on Activity of (S)-Mephenytoin 4'-Hydroxylase
(CYP2C19) in A Chinese Population
Meta-analysis of Phenotype and Genotype of NAT2 Deficiency in Chinese
Populations
The Induction Effect of Rifampicin on Activity of Mephenytoin 4'-hydroxylase Related
to M1 Mutation of CYP2C19 and Gene Dose
Evidence for Involvement of Polymorphic CYP2C19 and 2C9 in the N-demethylation
of Sertraline in Human Liver Microsomes
Effect of the Gene Dosage of CYP2C19 on Diazepam Metabolism in Chinese
Subjects
Phenotypic Polymorphism and Gender-related Differences of CYP1A2 Activity in a
Chinese Population
5-Hydroxylation of Omeprazole by Human Liver Microsomal Fractions from Chinese
Populations Related to CYP2C19 Gene Dose and Individual Ethnieity
Ethnic Differences in Drug Metabolism
Effect of the CYP2C19 Oxidation Polymorphism on Fluoxetine Metabolism in Chinese
Healthy Subjects
Pharmacokinetics of Sertraline in Relation to Genetic Polymorphism of CYP2C19
Plasma Caffeine Metaboite Ratio (17X/137X) in Vivo Associated with G-2964A and
C734A Polymorphisms of Human CYPIA2
O-Dealkylation of Fluoxetine in Relation to CYP2C19 Gene Dose and Involvement
of CYP3A4 in Human Liver Microsomes
Assessment of Cytochrome P450 Activity by a Five-drug Cocktail Approach
The Role of CYP2C19 in Amitriptyline N-demethylation in Chinese Subjects
Inducibility of CYPIA2 by Omeprazole in Vivo Related to the Genetic Polymorphism
of CYP 1A 2
Phenotypic Polymorphism of CYP2A6 Activity in a Chinese Population
Histamine N-methyltransferase Gene Polymorphisms in Chinese and Their Relationship
with Enzyme Activity in Erythrocytes
Isozyme-specific Induction of Low-dose Aspirin on Cytochrome P450 in Healthy
Subjects
Gly389Arg Polymorphism of β1-adrenergic Receptor is Associated with the
Cardiovascular Response to Metoprolol
Pharmacokinetics of Citalopram in Relation to Genetic Polymorphism of CYP2C19
The Distribution and Gender Difference of CYP3A Activity in Chinese Subjects
St John's Wort Induces Both Cytochrome P450 3A4一catalyzed Sulfoxidation and
2C19-dependent Hydroxylation of Omeprazole
liell8Val Genetic Polymorphism of CYP3A4 and Its Effects on Lipid-lowering
Efficacy of Simvastatin in Chinese Hyperlipidemic Patients
Gender Specific Association of CYP2C9’3 with Hyperlipidaemia in Chinese
β1-Adrenergic Receptor Polymorphisms Influence the Response to Metoprolol
Monotherapy in Patients with Essential Hypertension
Effect of SL001B 1 Genetic Polymorphism on the Pharmacokinetics of Nateglinide
Frequency of Genetic Polymorphisms of COX1,GP IIIa and P 2Y1 in a Chinese
Population and Association with Attenuated Response to Aspirin
SLC01B 1 521T→C Functional Genetic Polymorphism and Lipid-lowering Efficacy
of Multiple-dose Pravastatin in Chinese Coronary H eart Disease Patients
The Effect of Herbal Medicine Baicalin on Pharmacokinetics of Rosuvastatin
Substrate of Organic Anion-transporting Polypeptide 181
Hepatic Nuclear Factor l a Inhibitor Ursodeoxycholic Acid Influences Pharmacokinetics
of the Organic Anion Transporting Polypeptide 181 Substrate Rosuvastatin and
Bilirubin
Effects of Ginkgo Biloba Extract on the Pharmacokinetics of Bupropion in H ealthy Volunteers
Plant Polyphenol Curcumin Significantly Affects CYPIA2 and CYP2A6 Activity in
Healthy.Male Chinese Volunteers
Pharmacogenetics of Drugs Withdrawn from the Market-
三、周宏灏院士的主要学术著作
药理学
Textbook of Pharmacology
Case FilesTM Pharmacology
Pharmacology
遗传药理学(第2版)
四、周宏灏院士重要学术报告、重要讲话
Ethnic Differences in Drug Response
Pharmacogenetic Research about Natural Medicine Effect of Natural Medicine on CYP450
Ethnic Differences in Drug Metabolism
Genetic Polymorphism of CYP2C19 in Chinese Populations
Pharmacogenetics ant’i Pharmacogenomics in Asian Populations and Impaci on Clinical
Pharmacology
Racial Differences in Drug Response Reflect Differences in Distribution of Polymorphic
Traits
Pharmacogenetic and Pharmacogenomic Research in China
Ethnicity,Genet:ics and Tailored Pharmacotherapy
个体化药物治疗的研究与开发
药物基因组学研究技术成果在药物临床评价中的应用
在临床试验中不能忽视亚洲人群种族差异的基因多态性
药物代谢酶基因多态性与个体化药物治疗
个体化医学的实施与展望
五、周宏灏院士学术年表
周宏灏院士论文目录
周宏灏院士专著目录
周宏灏院士科研与教学成果目录
周宏灏院士获国家发明专利目录
第三部分 治学之道
勤勉严谨做学问 情系祖国育桃李
遗传药理学研究的先行者
善于发现 勇于挑战——访临床药理学家周宏灏院士
中国遗传药理学开拓者周宏灏:立志如山 行道如水
周宏灏:中国个体化用药的“拓荒者”
让患者用药更精确
用药也需“量体裁衣”——访我国著名遗传药理学家周宏灏教授
第四部分 大师风范
一、感悟、经验与情怀
做人做事做学问
心系学子 桃李芬芳 以德服人从严治学
医学教育不能硬套综合大学管理体制——中国工程院院士周宏灏谈我国医学教育现状与改革
春蚕到死丝方尽,人至期颐亦不休
我的情操
二、部分学生的代表性论文
Effect of Asymmet ric Dimethylarginine on OsteobIastic Differentiation
Effect of SLCOIB1 Genetic Polymorphism on the Pharmacokinetics of Nateglinide
Evidence for Involvement of Calcitonin Gene-Related Peptide in Nitroglycerin Response
and Association with Mitochondrial Aldehyde Dehydrogenase-2 (ALDH2) Glu504Lys
Polymorphism
Molecular Population Genetics of Human CYP3A Locus. Signatures of Positive
Selection and Implications for Evolutionary Environmental Medicine
Coupling HPLC to on-line, Post-column (bio) Chemical Assays for High-resolution
Screening of Bioactive Compounds from Complex Mixtures
KCNJ 11 Lys23Glu and TCFTL2 rs290487(C/T) Polymorphisms affect Therapeutic
Efficacy of Repaglinide in Chinese Patients with Type 2 Diabetes
Inhibition of the Organic Anion-transporting Polypeptide 1B1 by Quercetin: An
in Vitro and in Vivo Assessment
Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy
by Regulating DNA Repair
The Pregnane X Receptor Agonist St John's Wort Has No Effects on the Pharmacokinetics
and Pharmacodynamics of Repaglinide
Effects of Lignans Extracted from Eucornmia Ulmoides and Aldose Reductase Inhibitor
Epalrestat on Hypertensive Vascular Remodeling
ABCC2 Polymorphisms and Haplotype are Associated with Drug Resistance in Chinese
Epileptic Patients
Theragnostics Meets Traditional Chinese Medicine: Rational Prediction of Drug-herb
Interactions
Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small
Cell Lung Cancer (NSCLC) Patients
Protective Effects of Eucommia Lignans Against Hypertensive Renal Injury by
Inhibiting Expression of Aldose Reductase
Translational Regulation of RPA2 Via Internal Ribosomal Entry Site and by eIF3a
Effect of NR3C2 Genetic Polymorphisms on the Blood Pressure Response to Enalapril
Treatment
The KCNH2 Genetic Polymorphism (1956, C>T) Is a Novel Biomarker That Is Associated
with CCB and α, β-ADR Blocker Response in EH Patients in China
Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan
Current Pharmacogenomic Studies on hERG Potassium Channels
Deficiency of Multidrug and Toxin Extrusion 1 Enhances Renal Accumulation of
Paraquat and Deteriorates Kidney Injury in Mice
Effects of the PerOXisome Proliferator Activatedl Receptor-γ Coactivator-la (PGC-la)
Thr394Thr and Gly482Ser Polymorphisms on Rosiglitazone Response in Chinese
Patients with Type 2 Diabetes Mellitus
Characterization and Analyses of Multidrug Resistance-associated Protein 1(MRP1/
ABCC1) Polyrnorphisms in Chinese Population
第五部分 社会影响
我学者首次发现不同种族对药物的差异性
Effectiveness of Drugs May be Influenceol by Racial and Ethnic History
深入了解中国人的心脏
种族与药物的治疗效应
β-受体阻滞药效应呈现种族差异
药物效应的种族差异
我国医学科技占世界之首成果巡礼
Biolnedicine
DNA Chips Bring Personalizeol Medicine to China
开拓国际临床药理新领域——记中国工程院院士周宏灏
世界首张个体化用药基因芯片初步研制成功
个体化用药成为焦点
用多少药,问问你的遗传基因
基因芯片:有助于药物治疗个体化
用药也可“量体裁衣”
周宏灏教授当选世界药理学联合会药物代谢学会理事
省儿童医院聘请周宏灏为终身首席科学家
引领人类个体化用药新时代的人——记我国著名临床与遗传药理学家周宏灏教授
研发一体化做强湖南医药产业——访中国遗传药理学专家、中南大学临床药理研究所
所长、中国工程院院士周宏灏教授
种族差异、遗传及个体化药物治疗
第六部分 人生风采
成长历程
教书育人
学术交流
珍贵合影
人文情怀